Number of Clinical Trials 2004

Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.

72 data points••Global Coverage•Number of clinical trials | ClinicalTrials.gov via Our World in Data•

Newer data is available: Number of Clinical Trials by country 2024 →

Highest
United States
1,162
Lowest
Sudan
1
Median country
3
Countries with data
72

Where does your country rank? Pick it to see its position.

Related Health statistics

More ↓

Interactive Map

Loading interactive map...

Complete Data Rankings

↑Top 10 Countries

  1. #1United States flagUnited States
  2. #2Canada flagCanada
  3. #3Germany flagGermany
  4. #4United Kingdom flagUnited Kingdom
  5. #5France flagFrance
  6. #6Belgium flagBelgium
  7. #7Denmark flagDenmark
  8. #8Taiwan flagTaiwan
  9. #9Australia flagAustralia
  10. #10Japan flagJapan

Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.

↓Bottom 10 Countries

  1. #72Sudan flagSudan
  2. #71Sierra Leone flagSierra Leone
  3. #70Senegal flagSenegal
  4. #69Romania flagRomania
  5. #68Peru flagPeru
  6. #67New Zealand flagNew Zealand
  7. #66Mali flagMali
  8. #65Lebanon flagLebanon
  9. #64Jordan flagJordan
  10. #63Indonesia flagIndonesia

Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.

Insights by country

1

Guinea-Bissau

In 2004, Guinea-Bissau had a global rank of #46 with a total of 2 clinical trials. This number is relatively low compared to regional peers, reflecting limited research infrastructure and funding in the country. The small size of the population and ongoing economic challenges further hinder the development of a robust clinical research environment.

2

Russia

In 2004, Russia ranked #29 globally with a total of 5 clinical trials. This figure is relatively low compared to other countries, highlighting a significant gap in clinical research activity, especially when contrasted with leading nations in the field. The limited number of clinical trials in Russia can be attributed to a combination of regulatory challenges and a lack of investment in research infrastructure, which have historically hindered the development of the pharmaceutical sector.

3

Hungary

In 2004, Hungary ranked #42 globally with a total of 2 clinical trials. This figure is notably lower than many of its Central European neighbors, indicating a limited engagement in clinical research at that time. Factors contributing to Hungary's low number of trials included a smaller population base and regulatory challenges that may have hindered the growth of clinical research initiatives.

4

Iran

In 2004, Iran ranked #43 globally with a total of 2 clinical trials. This figure is notably lower than the global average, reflecting the challenges faced by the country's healthcare system compared to leading nations in clinical research. Factors such as economic sanctions, limited access to international collaboration, and a focus on domestic health issues have constrained the growth of clinical trials in Iran.

5

Gambia

In 2004, Gambia ranked #24 globally with a total of 6 clinical trials. This figure is notable as it surpasses many neighboring countries, reflecting Gambia's commitment to advancing medical research despite its limited resources. The country's strategic location along the Atlantic coast and its focus on improving healthcare infrastructure have facilitated these clinical endeavors.

6

Portugal

In 2004, Portugal ranked #34 globally with a total of 4 clinical trials. This figure is notably lower than the top-ranked country, the United States, which leads with thousands of trials. Factors contributing to Portugal's clinical trial landscape include its relatively smaller population and a focus on other sectors in its healthcare system, which may limit the scope and funding for clinical research initiatives.

7

Austria

In 2004, Austria ranked #26 globally with a total of 5 clinical trials. This figure is notably lower than that of leading countries in clinical research, reflecting the competitive landscape of the field. Austria's relatively modest number of trials can be attributed to its smaller population and a healthcare system that emphasizes efficiency over extensive clinical research initiatives. Additionally, stringent regulatory frameworks may impact the speed and volume of trial approvals compared to larger nations.

8

Bulgaria

Bulgaria ranked #51 globally with a total of 1 clinical trial in 2004. This number reflects a relatively low engagement in clinical research compared to regional neighbors, which often have more robust health research infrastructures. The limited number of clinical trials can be attributed to Bulgaria's transitional economy and challenges in attracting international pharmaceutical investments during this period.

9

Indonesia

In 2004, Indonesia ranked #60 globally with 1 clinical trial. This figure is notably low compared to regional peers, reflecting the broader challenges in the country's healthcare research infrastructure. Contributing factors include limited funding for medical research and regulatory hurdles that can impede the initiation of clinical trials. Additionally, the country's diverse population and varying health needs complicate the standardization of research protocols.

10

Kenya

In 2004, Kenya ranked #44 globally with a total of 2 clinical trials. This figure is notably lower than the global average, reflecting challenges in the research infrastructure compared to countries with more robust clinical research environments. Factors such as limited funding for medical research and a relatively nascent pharmaceutical sector have contributed to this low number of trials in the country.

Analysis & Context

The United States led the world in the Number of Clinical Trials in 2004, with a total of 1162 trials, while globally, the number of trials ranged from 1 to 1162 across the 72 countries with data available. The global average number of clinical trials was 25.15, with a median of 3.00, reflecting a significant concentration of research activity in a few countries.

Concentration of Clinical Trials in Developed Nations

The data from 2004 highlights a marked concentration of clinical trials in developed nations, with the United States conducting 1162 trials, significantly more than any other country. This is likely due to several factors, including the presence of a robust pharmaceutical industry, substantial funding for medical research, and a high number of research institutions. Canada and Germany, with 81 and 71 trials respectively, also reflect this trend, benefiting from similar economic and infrastructural advantages.

Other developed countries such as the United Kingdom and France conducted 45 and 36 trials, respectively. These figures underscore the role of national healthcare systems and government policies that support clinical research. In contrast, developing nations such as Bulgaria and Senegal reported only 1 trial each, indicating economic and infrastructural limitations in supporting large-scale clinical research.

Factors Driving Clinical Trial Numbers

The number of clinical trials in a country is influenced by several factors beyond just economic capability. Regulatory environments, availability of research participants, and healthcare infrastructure all play critical roles. For instance, countries like Denmark and Belgium, with 28 trials each, benefit from streamlined regulatory processes and high healthcare standards, making them attractive locations for conducting trials.

In Japan and Taiwan, each conducting 24 trials, the presence of advanced technological industries and high investment in research and development contribute to their ability to conduct numerous clinical trials. Conversely, countries with stringent regulatory environments or limited healthcare infrastructure may struggle to attract or support such research activities.

Year-over-Year Trends and Influencers

The year 2004 saw significant changes in the number of clinical trials conducted compared to previous years. The United States experienced a substantial increase of 316 trials, a 37.4% rise, reflecting the country's expanding pharmaceutical industry and increased investment in medical research. Similarly, Canada and Germany saw increases of 29 trials each, with Canada experiencing a 55.8% rise and Germany a 69.0% rise, likely driven by enhanced research funding and international collaboration.

Conversely, countries like Austria and Israel saw decreases of 4 and 2 trials, respectively. This could be attributed to changes in research funding priorities or shifts in regulatory policies. The data shows that while some countries are expanding their research capabilities, others face challenges that may limit their participation in global clinical research initiatives.

Implications and Global Impact

The disparity in the number of clinical trials among countries has significant implications for global health and medical innovation. Countries with higher numbers of trials, such as the United States, not only advance their own healthcare systems but also contribute to global medical knowledge and innovation. However, the low number of trials in many countries highlights the need for increased investment and international collaboration to ensure equitable access to the benefits of clinical research.

Efforts to increase the number of clinical trials in underrepresented regions could lead to improved healthcare outcomes and economic benefits. By addressing regulatory and infrastructural barriers, more countries could participate in and benefit from the advancements generated by clinical research.

Frequently Asked Questions About Number of Clinical Trials in 2004

Which country had the highest number of clinical trials in 2004?

The United States had the highest number of clinical trials in 2004, with a total of 1,162 trials.

What was the average number of clinical trials conducted per country in 2004?

The average number of clinical trials conducted per country in 2004 was 25.15.

Which country had the lowest number of clinical trials in 2004?

Bulgaria had the lowest number of clinical trials in 2004, with only 1 trial conducted.

What is the median number of clinical trials conducted per country in 2004?

The median number of clinical trials conducted per country in 2004 was 3.

How many countries conducted only 1 clinical trial in 2004?

Ten countries conducted only 1 clinical trial in 2004, including Bulgaria, Trinidad and Tobago, and Sierra Leone.

Which countries were in the top 3 for the number of clinical trials in 2004?

The top 3 countries for the number of clinical trials in 2004 were the United States with 1,162 trials, Canada with 81 trials, and Germany with 71 trials.

Data Source

Number of clinical trials | ClinicalTrials.gov via Our World in Data

Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".

Visit Data Source

Cite this page

Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2004. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2004

The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.

›Embed this ranking on your site

Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.

Preview

Historical Data by Year

Explore Number of Clinical Trials data across different years. Compare trends and see how statistics have changed over time.